| Emily Conroy, MS, CCC-SLP | |
|
2000 Old West Chester Pike, Havertown, PA 19083-2712 | |
| (610) 536-2377 | |
| Not Available |
| Full Name | Emily Conroy |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2000 Old West Chester Pike, Havertown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063034254 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SL012323 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Conroy, MS, CCC-SLP 18 S Overhill Rd, Media, PA 19063-1503 Ph: (484) 866-5932 | Emily Conroy, MS, CCC-SLP 2000 Old West Chester Pike, Havertown, PA 19083-2712 Ph: (610) 536-2377 |
News Archive
A new study published in the journal Respirology reveals that a high level of soft drink consumption is associated with asthma and/or chronic obstructive pulmonary disease (COPD).
Scientists at Jefferson Medical College have received a four-year, $3 million National Institutes of Health grant funded by the National Heart, Lung and Blood Institute to study variations of platelet function, specifically, the genetics of platelet gene expression. The study aims to find data that can be translated into novel therapeutic strategies and develop better predictors of cardiovascular disease.
A derivative of a common culinary spice found in Indian curries could offer a new treatment hope for sufferers of the painful condition tendinitis, an international team of researchers has shown.
BSD Medical Corporation today announced that published study results demonstrated improvement in overall survival, tumor response rates, and local tumor control from the addition of hyperthermia therapy, delivered using the BSD-2000 Hyperthermia System, to the standard treatment regimen for 45 patients with high-risk bladder cancer.
Clinuvel Pharmaceuticals Limited today announced that it has submitted a marketing authorisation application (MAA) for its first-in-class drug SCENESSE (afamelanotide 16mg implant) to the European Medicines Agency.
› Verified 4 days ago
Mrs. Beth Rosenau Appelbaum, M.A.,CCC-SP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 N Belfield Ave, Sunny Days, Havertown, PA 19083 Phone: 610-449-1600 Fax: 610-449-2655 | |
Alyssa Tarantino, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2559 Prescott Rd, Havertown, PA 19083 Phone: 860-853-8680 | |
Kristina Elizabeth Howard, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2410 W Township Line Rd, Havertown, PA 19083 Phone: 484-535-2278 | |
Judy Montevideo-berry, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 N Belfield Ave, Sunny Days, Havertown, PA 19083 Phone: 610-449-1600 Fax: 610-449-2655 | |
Mrs. Sandra A Schwartz, SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 301 West Chester Pike, Suite 101, Havertown, PA 19083 Phone: 610-446-6900 Fax: 610-446-0204 | |
Ms. Beth S Collins, ED.M. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 256 Frederick Rd, Havertown, PA 19083 Phone: 610-446-1305 |